Appili Therapeutics Inc (APLI.TO) saw a dramatic decline of 33.33% in its stock price today, closing at just CA$0.01.
In a disappointing turn of events for investors, Appili Therapeutics experienced a significant drop in its stock price during the last trading session. With no major news to explain the plunge, the company’s market cap now stands at just CA$1,985,491, raising concerns about its financial health and future prospects.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$1.32M
52W high
$0.04
52W low
$0.01
1W change
+50.00%
Beta
-0.21
Analyst Price Targets
Based on analyst covering APLI
Wall Street analysts forecast APLI stock price to rise 900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+900.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
207.3%
Annualized
90-Day Vol
222.9%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.03 |
| 60 trading days | C$0.02 | C$0.01 – C$0.04 |
| 90 trading days | C$0.02 | C$0.00 – C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Today's sharp decline highlights the volatility and risks of investing in small-cap biotech firms like Appili Therapeutics, especially when there are no strong operational updates or market catalysts.
Stock Plummets 33.33% in One Day
Appili Therapeutics Inc's stock price fell to CA$0.01, reflecting investor concerns over its financial viability.
Bull case
Investors might find some optimism in Appili's recent announcements about funding and operational advancements. If the company can effectively leverage these developments, they could lay the groundwork for future recovery.
Bear case
The absence of significant news accompanying today's drop raises concerns about investor confidence and the company's ability to sustain operations, particularly given its low market cap.
Market Reaction
Advertisement
The significant drop in Appili Therapeutics' stock price today reflects a general lack of investor confidence. With the stock closing at CA$0.01, there are worries about the company's ability to attract further investment, especially with a market capitalization of just under CA$2 million.
Company Overview
Appili Therapeutics Inc focuses on developing innovative therapeutics for infectious diseases. Despite recent announcements about operational advancements and funding, the company has struggled to maintain investor interest, as shown by today's sharp decline. For more insights, check out our detailed analysis on APLI.TO.
Looking Ahead
Moving forward, investors should closely monitor Appili's upcoming announcements and financial reports. The company's ability to stabilize its stock price will depend on showing tangible progress in its clinical programs and securing additional funding. For further updates, visit our APLI.TO page.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
